SK
Highly Engaged Employees
Holding Companies & Conglomerates · South Korea · 10K+ Employees
View Company Info for Free
Overview
Headquarters
26 Jong-ro Jongno-gu, Seoul, 03188, Sout...Phone Number
(281) 849-9620Website
sk-inc.comRevenue
$90.3 BillionStock Symbol
034730Industry
About SK
SK Org Chart
Is SK your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
SK, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on SK recently announced quarterly report
Funding: Get notified immidiatlly once SK has new funding data
Congratulate Masked Content for being promoted to Masked Content at SK
Check if SK has recently received funding, and reach out quickly before it becomes old news!
Click to see if SK had a recent Job posting/layoffs
Check out if SK is spiking on competitors!
Product Launch: Get notified when SK launches new products
Recommended Actions
Reach out to Masked Content who joined SK as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
SK is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
SK is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about SK.
SK Tech Stack
A closer look at the technologies used by SK
Most Recent Scoops
SK News & Media
SK Life Science Labs to Present New Preclinical Data on Targeted Protein Degradation at AACR Annual Meeting 2026
Key Facts Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline Programs featured: selective p300 and PRMT5 degraders p300 degrader data demonstrate: Deep anti-tumor activity in CBP mutant cancers (synthetic lethality) Broad efficacy...SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation
New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- SK Biopharmaceuticals, CO., Ltd., a biotech company...SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation
New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, Nov. 27, 2025 /PRNewswire/ -- SK Biopharmaceuticals, CO., Ltd., a biotech company specializing in research, development, and commercialization of treatments for central nervous system (CNS) disorders and oncology, announced a license agreement with the Wisconsin Alumni Research Foundation (WARF) to acSK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting
PARAMUS, N.J. , Nov. 21, 2025 /PRNewswire/ -- SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., will present new data on cenobamate, an anti-seizure medication, at the 2025 American Epilepsy...
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SK
SK Inc. focuses on operating in energy, chemicals, information and communications, biopharmaceutical, mobility, materials, logistics, and service business areas. The company was formerly known as SK Holdings Co., Ltd and changed its name to SK Inc. in March 2021. SK Inc. was founded in 1962 and is headquartered in Seoul, South Korea.... Read More